ANDRES GIL, JOSE IGNACIO,LETAVIC, MICHAEL A.,RECH, JASON C.,RUDOLPH, DALE A.,SOYODE-JOHNSON, AKINOLA,CHROVIAN, CHRISTA C.
申请号：
CA2960972
公开号：
CA2960972A1
申请日:
2015.08.26
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
The present invention is directed to compounds of Formula (I), which includes enantiomer and diasteromers thereof: These compounds are suitable for use in the treatment of diseases associated with P2X7 receptor activity such as diseases of the autoimmune and inflammatory system, diseases of the nervous and neuro-immune system, diseases involved with neuroinflammation of the Central Nervous System (CNS) or diseases of the cardiovascular, metabolic, gastrointestinal and urogenital systems.
